Thrivent Financial for Lutherans
AMED

Thrivent Financial for Lutherans’s Amedisys AMED Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,711
Closed -$759K – 2371
2025
Q2 		$759K Buy
7,711
+32
+0.4% +$3.03K ﹤0.01% 1949
2025
Q1 		$711K Sell
7,679
-27
-0.4% -$2.49K ﹤0.01% 1917
2024
Q4 		$700K Buy
7,706
+39
+0.5% +$3.58K ﹤0.01% 2098
2024
Q3 		$740K Sell
7,667
-218
-3% -$21.3K ﹤0.01% 2073
2024
Q2 		$724K Sell
7,885
-293
-4% -$27.2K ﹤0.01% 2043
2024
Q1 		$754K Buy
8,178
+26
+0.3% +$2.44K ﹤0.01% 2047
2023
Q4 		$775K Sell
8,152
-19
-0.2% -$1.77K ﹤0.01% 2000
2023
Q3 		$763K Sell
8,171
-240
-3% -$22.2K ﹤0.01% 1898
2023
Q2 		$769K Sell
8,411
-48,658
-85% -$3.99M ﹤0.01% 1964
2023
Q1 		$4.2M Buy
57,069
+36,623
+179% +$3.17M 0.01% 881
2022
Q4 		$1.71M Sell
20,446
-30,054
-60% -$2.71M ﹤0.01% 1356
2022
Q3 		$4.89M Buy
50,500
+29,378
+139% +$3.5M 0.01% 809
2022
Q2 		$2.22M Buy
21,122
+27
+0.1% +$3.45K 0.01% 1176
2022
Q1 		$3.63M Sell
21,095
-77
-0.4% -$11.5K 0.01% 1007
2021
Q4 		$3.43M Sell
21,172
-217,358
-91% -$34.9M 0.01% 1064
2021
Q3 		$35.6M Sell
238,530
-324,330
-58% -$67.4M 0.07% 299
2021
Q2 		$138M Buy
562,860
+199,839
+55% +$52.4M 0.28% 79
2021
Q1 		$96.1M Buy
363,021
+354,431
+4,126% +$100M 0.21% 113
2020
Q4 		$2.52M Sell
8,590
-154
-2% -$39.5K 0.01% 1170
2020
Q3 		$2.07M Sell
8,744
-200
-2% -$45.5K 0.01% 1140
2020
Q2 		$1.78M Buy
8,944
+516
+6% +$96.2K 0.01% 1133
2020
Q1 		$1.55M Hold
8,428
– – 0.01% 1070
2019
Q4 		$1.41M Buy
8,428
+74
+0.9% +$11K ﹤0.01% 1239
2019
Q3 		$1.09M Buy
8,354
+653
+8% +$85K ﹤0.01% 1350
2019
Q2 		$935K Buy
7,701
+184
+2% +$21.8K ﹤0.01% 1458
2019
Q1 		$927K Sell
7,517
-12,912
-63% -$1.62M ﹤0.01% 1428
2018
Q4 		$2.39M Buy
20,429
+675
+3% +$79.6K 0.01% 778
2018
Q3 		$2.47M Buy
19,754
+125
+0.6% +$13.8K 0.01% 826
2018
Q2 		$1.68M Buy
19,629
+419
+2% +$30.8K 0.01% 980
2018
Q1 		$1.16M Buy
19,210
+1,539
+9% +$87.7K ﹤0.01% 1148
2017
Q4 		$931K Buy
17,671
+348
+2% +$18.3K ﹤0.01% 1305
2017
Q3 		$969K Buy
17,323
+410
+2% +$21.7K ﹤0.01% 1179
2017
Q2 		$1.06M Buy
16,913
+1,210
+8% +$70.5K ﹤0.01% 1091
2017
Q1 		$802K Buy
15,703
+570
+4% +$27.2K ﹤0.01% 1291
2016
Q4 		$645K Buy
15,133
+880
+6% +$37.4K ﹤0.01% 1381
2016
Q3 		$676K Buy
14,253
+540
+4% +$26.9K ﹤0.01% 1312
2016
Q2 		$692K Buy
13,713
+460
+3% +$23.2K ﹤0.01% 1264
2016
Q1 		$641K Buy
13,253
+1,120
+9% +$43.2K ﹤0.01% 1269
2015
Q4 		$477K Buy
12,133
+350
+3% +$14K ﹤0.01% 1373
2015
Q3 		$447K Sell
11,783
-1,350
-10% -$56.9K ﹤0.01% 1262
2015
Q2 		$522K Buy
13,133
+600
+5% +$18.7K ﹤0.01% 1091
2015
Q1 		$336K Buy
12,533
+700
+6% +$19.7K ﹤0.01% 1318
2014
Q4 		$347K Sell
11,833
-250
-2% -$6.17K ﹤0.01% 1306
2014
Q3 		$244K Sell
12,083
-50
-0.4% -$965 ﹤0.01% 1484
2014
Q2 		$203K Buy
12,133
+300
+3% +$4.25K ﹤0.01% 1625
2014
Q1 		$176K Hold
11,833
– – ﹤0.01% 1495
2013
Q4 		$173K Buy
11,833
+200
+2% +$3.22K ﹤0.01% 1516
2013
Q3 		$200K Buy
11,633
+200
+2% +$2.97K ﹤0.01% 1437
2013
Q2 		$133 Buy
+11,433
New +$131K ﹤0.01% 1511

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Thrivent Financial for Lutherans's AMED Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,711 shares — an estimated $759K sold.

Thrivent Financial for Lutherans first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $138M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 7,711 Amedisys shares in Q3 2025, an estimated $759K.
  • Thrivent Financial for Lutherans first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Thrivent Financial for Lutherans's Amedisys position peaked at $138M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.